AUDREY LANDS: Open Payments
NPI 1528603511 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 102 payments from 21 companies in 2025. Trend: 2023 $1,551 · 2024 $2,144 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $324 |
| ABBVIE INC. | 33 | $277 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $177 |
| Novo Nordisk Inc | 9 | $173 |
| Eisai Inc. | 6 | $157 |
| Viatris Specialty LLC | 9 | $154 |
| Amgen Inc. | 5 | $85 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $68 |
Products named: FASENRA, Kerendia, Leqembi, YUPELRI, QULIPTA, KRYSTEXXA, VRAYLAR, Ozempic.
Industry payments across AZ — which companies pay providers there.
